combination of hmg-coa reductase inhibitors with phosphodiesterase 4 inhibitors for the treatment of inflammatory lung diseases

• 收藏
• 分享

专利权人:

NYCOMED GMBH

发明人:

STEFAN-LUTZ WOLLIN,ANDREA WOHLSEN,CLEMENS BRAUN,DEGENHARD MARX

申请号：

BRPI0713768

公开号：

BRPI0713768A2

申请日:

2007.07.03

申请国别(地区):

BR

年份:

2012

代理人:

摘要：

COMBINATION OF HMG-CoA REDUCTASE INHIBITORS WITH PHOSPHODIESTERASE 4 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY PULMONARY DISEASES. The present invention relates to the combined use of a PDE4 inhibitor with a reductase inhibitor and HMG-CoA for the preventive and curative treatment of an inflammatory lung disease.COMBINAçãO DE INIBIDORES DE REDUCTASE DE HMG-CoA COM INIBIDORES DE FOSFODIESTERASE 4 PARA O TRATAMENTO DE DOENçAS PULMONARES INFLAMATóRIAS. A presente invenção refere-se ao uso combinado de um inibidor de PDE4 com um inibidor de reductase e HMG-CoA para o tratamento preventivo e curativo de uma doença pulmonar inflamatória.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/